Category Archives: Health
Latest From Health
BIO supports policy changes that protect patients’ ability to obtain access to the prescription drugs they need including policies that bolster enforcement of existing nondiscrimination requirement to ensure patients with high-cost health conditions are not penalized. A recent assessment of 2016 Qualified Health Plans in the Exchange Marketplace in 14 states, conducted by Harvard’s Center for Health Law and Policy Innovation (CHLPI), raises significant concerns, noting “there is increasing evidence that some QHPs are structured Read More >
In the United States, 1 in 9 Americans has kidney disease, and most don’t know it. The problem is particularly acute in the Washington, DC metropolitan area, where more than 700,000 people are affected, nearly 7,000 patients are on dialysis and more than 1,700 people are waiting for a life-saving kidney transplant. The National Kidney Foundation’s community-based initiative to educate about the kidneys, KEEP Healthy, aims to reduce those numbers by teaching participants to identify Read More >
In case you missed it, the Fort Worth Star-Telegram ran an op-ed by Thomas P. Stossel, American Cancer Society Professor of Medicine at Harvard and a visiting scholar of the American Enterprise Institute, discussing the Democratic Presidential Candidates plans for drug pricing controls and the adverse impact they will have on patients. Read more in the Star-Telegram.
The NIH Office of Science Policy (OSP) works on a wide range of issues including biosafety, biosecurity, genetic testing, genomic data sharing, human subjects protections, the organization and management of the NIH, and the outputs and value of NIH-funded research. This is accomplished through a wide range of analyses and reports, commentary on emerging policy proposals, and the development of policy proposals for consideration by NIH, the Federal government, and the public. To better align Read More >
Writing in the Morning Consult, former Senator Judd Gregg explains critical role of federal programs in preparing our nation for viral outbreaks and other biohazards that threaten to cause devastating harm to our national security. Because there is no commercial market for medical countermeasures to respond to attacks from chemical, biological, nuclear and radiological threats, in 2004 Congress passed the Project BioShield Act, which created the Project BioShield Special Reserve Fund (SRF) to incentivize research Read More >